New drugs and targets for asthma and COPD:
Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions....
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Basel
Karger
2010
|
Schriftenreihe: | Progress in respiratory research
Vol. 39 |
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors.<br>Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists |
Beschreibung: | Reporting the latest progress |
Beschreibung: | 1 Online-Ressource (XIV, 310 Seiten) Diagramme |
ISBN: | 9783805595674 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV040237006 | ||
003 | DE-604 | ||
005 | 20220524 | ||
007 | cr|uuu---uuuuu | ||
008 | 120605s2010 |||| o||u| ||||||eng d | ||
015 | |a 10,N29 |2 dnb | ||
020 | |a 9783805595674 |c Online |9 978-3-8055-9567-4 | ||
024 | 7 | |a 10.1159/isbn.978-3-8055-9567-4 |2 doi | |
035 | |a (OCoLC)762137022 | ||
035 | |a (DE-599)BVBBV040237006 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-355 |a DE-703 |a DE-11 |a DE-1046 |a DE-19 | ||
082 | 0 | |a 616.238061 |2 22/ger | |
084 | |a YB 5700 |0 (DE-625)153141:12905 |2 rvk | ||
084 | |a 610 |2 sdnb | ||
245 | 1 | 0 | |a New drugs and targets for asthma and COPD |c volume editors: Trevor T. Hansel, Peter J. Barnes |
264 | 1 | |a Basel |b Karger |c 2010 | |
300 | |a 1 Online-Ressource (XIV, 310 Seiten) |b Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 1 | |a Progress in respiratory research |v Vol. 39 | |
500 | |a Reporting the latest progress | ||
520 | |a Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors.<br>Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists | ||
650 | 0 | 7 | |a Bronchialasthma |0 (DE-588)4069674-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Targeted drug delivery |0 (DE-588)4302415-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Obstruktive Ventilationsstörung |0 (DE-588)4213128-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Bronchialasthma |0 (DE-588)4069674-1 |D s |
689 | 0 | 1 | |a Obstruktive Ventilationsstörung |0 (DE-588)4213128-5 |D s |
689 | 0 | 2 | |a Targeted drug delivery |0 (DE-588)4302415-4 |D s |
689 | 0 | 3 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Hansel, Trevor T. |d 1956- |0 (DE-588)172588405 |4 edt | |
700 | 1 | |a Barnes, Peter J. |d 1946- |0 (DE-588)12063810X |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 978-3-8055-9566-7 |w (DE-604)BV036670885 |
830 | 0 | |a Progress in respiratory research |v Vol. 39 |w (DE-604)BV039163823 |9 39 | |
856 | 4 | 0 | |u https://karger.com/books/book/2950 |x Verlag |3 Volltext |
912 | |a ZDB-1-KEC |a ZDB-1-KEB | ||
940 | 1 | |q ZDB-1-KEC11 | |
940 | 1 | |q ZDB-1-KEB11 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-025093286 | ||
966 | e | |u https://karger.com/books/book/2950 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804149227009343488 |
---|---|
any_adam_object | |
author2 | Hansel, Trevor T. 1956- Barnes, Peter J. 1946- |
author2_role | edt edt |
author2_variant | t t h tt tth p j b pj pjb |
author_GND | (DE-588)172588405 (DE-588)12063810X |
author_facet | Hansel, Trevor T. 1956- Barnes, Peter J. 1946- |
building | Verbundindex |
bvnumber | BV040237006 |
classification_rvk | YB 5700 |
collection | ZDB-1-KEC ZDB-1-KEB |
ctrlnum | (OCoLC)762137022 (DE-599)BVBBV040237006 |
dewey-full | 616.238061 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.238061 |
dewey-search | 616.238061 |
dewey-sort | 3616.238061 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03297nmm a2200565zcb4500</leader><controlfield tag="001">BV040237006</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220524 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">120605s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">10,N29</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783805595674</subfield><subfield code="c">Online</subfield><subfield code="9">978-3-8055-9567-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1159/isbn.978-3-8055-9567-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)762137022</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040237006</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-1046</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.238061</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YB 5700</subfield><subfield code="0">(DE-625)153141:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">New drugs and targets for asthma and COPD</subfield><subfield code="c">volume editors: Trevor T. Hansel, Peter J. Barnes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel</subfield><subfield code="b">Karger</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 310 Seiten)</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Progress in respiratory research</subfield><subfield code="v">Vol. 39</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Reporting the latest progress</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors.<br>Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bronchialasthma</subfield><subfield code="0">(DE-588)4069674-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Obstruktive Ventilationsstörung</subfield><subfield code="0">(DE-588)4213128-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Bronchialasthma</subfield><subfield code="0">(DE-588)4069674-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Obstruktive Ventilationsstörung</subfield><subfield code="0">(DE-588)4213128-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Targeted drug delivery</subfield><subfield code="0">(DE-588)4302415-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hansel, Trevor T.</subfield><subfield code="d">1956-</subfield><subfield code="0">(DE-588)172588405</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barnes, Peter J.</subfield><subfield code="d">1946-</subfield><subfield code="0">(DE-588)12063810X</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">978-3-8055-9566-7</subfield><subfield code="w">(DE-604)BV036670885</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Progress in respiratory research</subfield><subfield code="v">Vol. 39</subfield><subfield code="w">(DE-604)BV039163823</subfield><subfield code="9">39</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://karger.com/books/book/2950</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-KEC</subfield><subfield code="a">ZDB-1-KEB</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-1-KEC11</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-1-KEB11</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025093286</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://karger.com/books/book/2950</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV040237006 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T00:19:40Z |
institution | BVB |
isbn | 9783805595674 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025093286 |
oclc_num | 762137022 |
open_access_boolean | |
owner | DE-12 DE-355 DE-BY-UBR DE-703 DE-11 DE-1046 DE-19 DE-BY-UBM |
owner_facet | DE-12 DE-355 DE-BY-UBR DE-703 DE-11 DE-1046 DE-19 DE-BY-UBM |
physical | 1 Online-Ressource (XIV, 310 Seiten) Diagramme |
psigel | ZDB-1-KEC ZDB-1-KEB ZDB-1-KEC11 ZDB-1-KEB11 |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | Karger |
record_format | marc |
series | Progress in respiratory research |
series2 | Progress in respiratory research |
spelling | New drugs and targets for asthma and COPD volume editors: Trevor T. Hansel, Peter J. Barnes Basel Karger 2010 1 Online-Ressource (XIV, 310 Seiten) Diagramme txt rdacontent c rdamedia cr rdacarrier Progress in respiratory research Vol. 39 Reporting the latest progress Asthma, allergy and chronic obstructive lung disease are common throughout the world and are increasing in incidence, particularly in the developing world. This volume provides a state-of-the-art account of the identification of new targets and the development of new therapies for these conditions. Some 40 chapters by clinical academics and senior members of the pharmaceutical industry detail the latest breakthroughs in research and development. In asthma, a promising approach is the use of therapy directed against specific Th2 responses through biological antagonists of IL-5, IL-4 and IL-13. There have also been major advances in our understanding of innate immune responses to pathogen-associated molecular patterns, and in the area of Toll-like receptors.<br>Up to date and comprehensive, this book will be of particular relevance to those working in the pharmaceutical industry (in preclinical research and clinical development), to academic researchers in the field of respiratory medicine, and to respiratory health care specialists Bronchialasthma (DE-588)4069674-1 gnd rswk-swf Targeted drug delivery (DE-588)4302415-4 gnd rswk-swf Obstruktive Ventilationsstörung (DE-588)4213128-5 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Bronchialasthma (DE-588)4069674-1 s Obstruktive Ventilationsstörung (DE-588)4213128-5 s Targeted drug delivery (DE-588)4302415-4 s Arzneimittelentwicklung (DE-588)4143176-5 s DE-604 Hansel, Trevor T. 1956- (DE-588)172588405 edt Barnes, Peter J. 1946- (DE-588)12063810X edt Erscheint auch als Druck-Ausgabe 978-3-8055-9566-7 (DE-604)BV036670885 Progress in respiratory research Vol. 39 (DE-604)BV039163823 39 https://karger.com/books/book/2950 Verlag Volltext |
spellingShingle | New drugs and targets for asthma and COPD Progress in respiratory research Bronchialasthma (DE-588)4069674-1 gnd Targeted drug delivery (DE-588)4302415-4 gnd Obstruktive Ventilationsstörung (DE-588)4213128-5 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
subject_GND | (DE-588)4069674-1 (DE-588)4302415-4 (DE-588)4213128-5 (DE-588)4143176-5 (DE-588)4143413-4 |
title | New drugs and targets for asthma and COPD |
title_auth | New drugs and targets for asthma and COPD |
title_exact_search | New drugs and targets for asthma and COPD |
title_full | New drugs and targets for asthma and COPD volume editors: Trevor T. Hansel, Peter J. Barnes |
title_fullStr | New drugs and targets for asthma and COPD volume editors: Trevor T. Hansel, Peter J. Barnes |
title_full_unstemmed | New drugs and targets for asthma and COPD volume editors: Trevor T. Hansel, Peter J. Barnes |
title_short | New drugs and targets for asthma and COPD |
title_sort | new drugs and targets for asthma and copd |
topic | Bronchialasthma (DE-588)4069674-1 gnd Targeted drug delivery (DE-588)4302415-4 gnd Obstruktive Ventilationsstörung (DE-588)4213128-5 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
topic_facet | Bronchialasthma Targeted drug delivery Obstruktive Ventilationsstörung Arzneimittelentwicklung Aufsatzsammlung |
url | https://karger.com/books/book/2950 |
volume_link | (DE-604)BV039163823 |
work_keys_str_mv | AT hanseltrevort newdrugsandtargetsforasthmaandcopd AT barnespeterj newdrugsandtargetsforasthmaandcopd |